Autopsy report · NCT02997189

Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss

“Negative Efficacy Results from the recently completed Phase 3 study 104-201506”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 10 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Otonomy, Inc.

Sponsor type

Industry

Conditions

Cisplatin Induced Hearing Loss

Interventions

OTO-104

Participants

12

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.